PROCAM

The PROCAM risk algorithm


Page: Go to Previous Page 4 of 9 Go to Next Page

The PROCAM risk calculator is based on a scoring system for risk factors derived from 10 year follow-up data of the PROCAM study (7, 9, 10). The algorithm was initially developed and validated in the cohort of 5,389 men (35 to 65 years of age) recruited before the end of 1985. Among those participants, 325 developed major coronary events within 10 years. The risk algorithm was expressed as a simple scoring scheme in order to make it relevant to clinical practice. To construct the algorithm, a Cox proportional hazards model was used. The prediction model includes age, LDL cholesterol, HDL cholesterol, triglycerides, smoking, diagnosis of diabetes, family history of MI, and systolic blood pressure. In contrast to the previous model generated by the Framingham Heart Study, the PROCAM score used triglycerides and family history of premature MI to calculate the risk score. The categories for the continuous variables in the PROCAM score, such as age, blood pressure, LDL cholesterol, and HDL cholesterol, were based on the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) guidelines (11). However, in the case of triglycerides, the categories were based on the guidelines of the International Task Force for Prevention of CHD (12). Categorical variables are history of diabetes, history of MI, and smoking habits. A score is assigned to each level of the respective risk factor and the total score is calculated by adding up the points for each risk factor. The sum of these points provides the estimate of overall cardiovascular risk. For each total score, the corresponding absolute risk of MI or CHD death within the next 10 years is obtained (13). In the PROCAM algorithm, the “high risk” group had a 10 year coronary event risk greater than 20%, which corresponded to a PROCAM score of 53 and above. This definition of “high risk” of coronary event was reached through consensus by the Second Joint Task Force of European and other Societies on Coronary Prevention (14). The American NCEP-ATP III guidelines (11) state that patients with an absolute risk of CHD exceeding 20% within the next 10 years should be considered at “high risk.” These patients require attention from health professionals and aggressive management of their modifiable risk factors. 


Reference
Previous Reference
Next Reference
7. Assmann G, Cullen P and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310-5.
9. Seidell JC, Bjorntorp P, Sjostrom L, et al. Regional distribution of muscle and fat mass in men--new insight into the risk of abdominal obesity using computed tomography. Int J Obes 1989; 13: 289-303.
10. Pollock ML, Hickman T, Kendrick Z, et al. Prediction of body density in young and middle-aged men. J Appl Physiol 1976; 40: 300-4.
11. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
12. Assmann G, Carmena R and Cullen P. for the International Task Force for Prevention of Coronary Heart Disease. Coronary heart disease:reducing the risk: the scientific background for the primary and secondary prevention of coronary heart disease: a worldwide view. Nutr Metab Cardiovasc Dis 1998; 205-71.
13. van der Kooy K, Leenen R, Seidell JC, et al. Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr 1993; 57: 327-33.
14. International Task Force for Prevention of Coronary Heart Disease, http://www.chd-taskforce.com/slidekit/kit12/slide2_d.htm, last accessed in August 2007.

Document Center


Managing cardiometabolic risk

Managing cardiometabolic risk

More

Could you comment on the biology of adipose tissue? By Max Lafontan, PhD

Could you comment on the biology of adipose tissue? By Max Lafontan, PhD

More

Waist circumference: Getting it right! By Robert Ross, PhD

Waist circumference: Getting it right! By Robert Ross, PhD

More

Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62

Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62

More

Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease

Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease

More